Lexaria Bioscience Corp. (LEXX)
$3.32+3.75%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $82M
- Beta
- 0.34
- P/E (TTM)
- -0.61
- Short % float
- 1.44%
- Days to cover
- 4.0
- SI change
- +53.4%
- 1W
- +15.28%
- 1M
- -18.02%
- vs SPY 1W
- +14.12%
- vs SPY 1M
- -21.02%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on LEXX?
- LOPJLB’s latest quantitative signal on Lexaria Bioscience Corp. (LEXX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LEXX in?
- Lexaria Bioscience Corp. (LEXX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lexaria Bioscience Corp. (LEXX) do?
- Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoid…